- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05697562
Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease
A Randomized Comparative Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease
SRAE is a promising treatment of bleeding HD as a minimally invasive approach without sphincter damage nor direct mucosal anorectal trauma. Feasibility, efficacy and safety were studied in several trials. A randomized controlled study should confirm the benefits of this technique and will define its therapeutic role in HD.
Embolization and DG-HAL are based on the same concept of vascular occlusion of hemorrhoidal branches of the rectal artery. Furthermore, DG-HAL and RBL are equally effective procedures. The assumption is that treatment with SRAE is not inferior in comparison to RBL or DG HAL in respectively patients without or with antiplatelet/anticoagulation therapy in terms of symptom control and bleeding (non-inferiority study).
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Virgini Van Buggenhout
- Phone Number: 50 14 +32 2 477
- Email: virgini.vanbuggenhout@uzbrussel.be
Study Contact Backup
- Name: Magali Surmont
- Phone Number: 60 01 +32 2 477
- Email: magali.surmont@uzbrussel.be
Study Locations
-
-
-
Jette, Belgium, 1090
- Recruiting
- UZ Brussel
-
Contact:
- Magali Surmont
- Phone Number: 60 11 +32 2 477
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients referred for Hemorrhoidal disease with bleeding are eligible. Significant bleeding is defined as a HBS of ≥ 5.
- Age > 18 years old;
- Sexes eligible for study: all
- Hemorrhoidal disease grade I-III according the Goligher classification with rectal bleeding as predominant symptom
- History of prior instrumental treatment of HD does not prohibit inclusion
- Able to understand and read Dutch, French or English
Exclusion Criteria:
- Permanent hemorrhoidal prolapse/grade IV hemorrhoidal disease
- Rectal prolapse
- History of proctological surgery for HD
- Acute complicated course of HD i.e. acute thrombosis (fluxio hemorrhoidalis or perianal hematoma)
- Anal stenosis, congenital of acquired
- Chronic anal fissure
- Active rectal inflammation, including peri-anal abscess (e.g. Inflammatory Bowel Disease, infectious,…)
- History of colorectal or anal cancer
- History of rectal or sigmoidal resection
- Portal hypertension and liver cirrhosis Child Pugh C
- Radiation rectitis
- Neurological disease involving anal sphincter musculature
- Severe psychiatric disorder
- Pregnancy
- Allergy to iodinated contrast agents
- Colorectal neoplasia as the cause of bleeding (excluded with a (virtual) colonoscopy in the last year)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: anticoagulation group with DG HAL
|
The procedure is performed in lithotomy position with a modified proctoscope including a Doppler transducer (THD device) under anesthesia during a one-day hospitalization.
This transanal Doppler guidance enables accurate detection and targeted suture ligation of the SRAs Following gel lubrication, the proctoscope is inserted through the anal canal reaching the low rectum, about 6-7 cm from the anal verge.
After identification of the best place for artery ligation, the Doppler system is turned off.
The artery will be directly ligated with a Z-stitch at the site of the best Doppler signal.
|
Active Comparator: anticoagulation group with SRAE
|
This technique is realized under local anesthesia during a one-day hospitalization. The interventional radiologist will perform the procedure in the angiography room. After local anesthesia right femoral artery puncture is performed and a 4 F or 5 F introducer sheath is placed using the Seldinger technique. With an appropriate 4 or 5 F catheter the superior rectal artery is catheterized. With a microcatheter the different branches are selectively occluded with microcoils. The endpoint of embolization is reached when all SRA branches above the pubic ramus are embolized, with cessation of flow distally or a static column of contrast. The procedure can be repeated with addition of the embolization of the middle rectal wall artery (MRA) in case of failure after 12 weeks. |
Placebo Comparator: no anticoagulation group with RBL
|
This instrumental technique is realized during consultation.
A rubber band is applied on top of each hemorrhoidal complex via a proctoscope.
This banding causes an ulceration which heals with resulting fibrosis.
The patient can receive a maximum of 3 RBL during each session, which can be repeated up to 3 times at a 6 weeks interval.
|
Active Comparator: no anticoagulation group with SRAE
|
This technique is realized under local anesthesia during a one-day hospitalization. The interventional radiologist will perform the procedure in the angiography room. After local anesthesia right femoral artery puncture is performed and a 4 F or 5 F introducer sheath is placed using the Seldinger technique. With an appropriate 4 or 5 F catheter the superior rectal artery is catheterized. With a microcatheter the different branches are selectively occluded with microcoils. The endpoint of embolization is reached when all SRA branches above the pubic ramus are embolized, with cessation of flow distally or a static column of contrast. The procedure can be repeated with addition of the embolization of the middle rectal wall artery (MRA) in case of failure after 12 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
symptom control
Time Frame: from baseline to 3 months
|
the main objective is to control the symptoms, for this the Hemorrhoidal Bleeding Score is to be used
|
from baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Symptom control
Time Frame: from baseline to 12 months
|
a secondary objective is to control the symptoms, for this the Hemorrhoidal Bleeding Score is to be used
|
from baseline to 12 months
|
Patient reported effectiveness
Time Frame: from baseline till 12 months
|
a secondary objective is to report patient effectiveness, this will be measured using Patient-Reported Outcome Measure-Haemorrhoidal Impact and Satisfaction score (PROM-HISS)
|
from baseline till 12 months
|
Patient reported effectiveness
Time Frame: from baseline till 12 months
|
a secondary objective is to report patient effectiveness, this will be measured using the 5-level EQ-5D-5L score
|
from baseline till 12 months
|
clinical effectiveness
Time Frame: from baseline till 12 months
|
a secondary objective is to report clinical effectiveness, this will be measured using the Goligher score
|
from baseline till 12 months
|
prevalence of complications
Time Frame: from baseline till 12 months
|
a secondary objective is to report the prevalence of complications, this will be measured using among others the pain score reported by Visual Analogue Scale (VAS)
|
from baseline till 12 months
|
prevalence of re-interventions
Time Frame: from baseline till 12 months
|
a secondary objective is to report the prevalence of re-interventions, this will be measured among others with the pain score reported by Visual Analogue Scale (VAS)
|
from baseline till 12 months
|
prevalence of fecal incontinence
Time Frame: from baseline till 12 months
|
a secondary objective is to report the prevalence of fecal incontinence, this will be measured using the Jorge-wexner score
|
from baseline till 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEMbol
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhoids
-
Vilnius UniversityBiolitec Pharma Ltd.UnknownHemorrhoids Second Degree | Hemorrhoids Third DegreeLithuania
-
Ventrus Biosciences, IncTerminatedInternal HemorrhoidsUnited States
-
Societa Italiana di Chirurgia ColoRettaleSICCR - Gaetano GalloCompletedSecond-degree HemorrhoidsItaly
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Universidade do PortoCompletedHemorrhoids, InternalPortugal
-
G & W Laboratories Inc.CompletedInternal HemorrhoidsUnited States
-
Kuwait Oil Company Ahmadi HospitalNetherlands: Ministry of Health, Welfare and SportsCompleted
-
Services Hospital, LahoreCompletedLength of Stay | Operative Time | Hemorrhoidectomy | Third Degree Hemorrhoids | Fourth Degree Hemorrhoids | Postoperative,PainPakistan
-
BayerCompletedAcute HemorrhoidsRussian Federation
-
Proctos KliniekRecruitingRectal Diseases | Hemorrhoids | PROM | Hemorrhoids, InternalNetherlands
Clinical Trials on Doppler-Guided Hemorrhoidal Artery Ligation (DG-HAL)
-
Russian Society of Colorectal SurgeonsUnknown
-
University Hospital, AkershusTerminatedSymptomatic Haemorrhoidal DiseaseNorway
-
Cantonal Hospital of St. GallenActive, not recruitingHemorrhoidsSwitzerland
-
Universidade do PortoCompleted
-
University Hospital, GrenobleRecruitingHemorrhoidal DiseaseFrance
-
Centre Hospitalier Departemental VendeeRecruitingHaemorrhoids | Internal Haemorrhoids | Grade II/III HaemorrhoidsFrance
-
Medical University InnsbruckCompletedThird Degree Hemorrhoids
-
Societa Italiana di Chirurgia ColoRettaleUnknown
-
Amalia Fleming General HospitalSismanoglio - Amalia Fleming General HospitalCompletedHemorrhoidal Disease